CRISIL Extends Timeline for Closure of Singapore Subsidiary to July 2027

BY ADMIN • FILED 21 Jul 2026, 2:12 PM

CRISIL Limited, a leading global analytics and ratings company, has informed the stock exchanges that it has extended the timeline for the proposed closure of its wholly-owned subsidiary, Coalition Development Singapore PTE. Ltd. The closure, which was earlier expected to be completed by July 21, 2026, is now anticipated by July 20, 2027, subject to obtaining the necessary statutory and regulatory approvals in Singapore.

The extension is procedural in nature and does not have any material impact on the company’s ongoing business operations or financial performance.

Closure Delayed Due to Regulatory Approvals

According to the company’s disclosure, the revised timeline is primarily due to pending approvals from the relevant regulatory authorities in Singapore. CRISIL emphasized that the subsidiary is already non-operational and has no ongoing business activities, meaning the delay is an administrative matter rather than an operational issue.

Once all required approvals are received, the company expects to complete the formal closure process.

Key Highlights

Subsidiary: Coalition Development Singapore PTE. Ltd.
Ownership: Wholly-owned subsidiary of CRISIL Limited.
Nature of Transaction: Proposed closure of the subsidiary.
Earlier Expected Completion: July 21, 2026.
Revised Expected Completion: July 20, 2027.
Reason for Extension: Pending statutory and regulatory approvals in Singapore.
Current Status: Subsidiary is non-operational with no active business operations.

Part of Corporate Simplification Strategy

The proposed closure forms part of CRISIL’s ongoing efforts to streamline its global corporate structure and improve operational efficiency. Rationalizing inactive entities helps reduce administrative complexities, simplify compliance requirements, and optimize the company’s international legal structure.

Since the subsidiary has already ceased operations, the extended closure timeline is not expected to affect CRISIL’s revenue, profitability, or core business activities.